keyword
https://read.qxmd.com/read/38720208/topical-tacrolimus-ointment-alone-versus-in-combination-with-microneedling-for-refractory-stable-vitiligo
#1
COMPARATIVE STUDY
Afshan Kiran, Seemab Khan, Najia Ahmed, Maira Ali
OBJECTIVE: To assess the efficacy of microneedling in combination with topical tacrolimus ointment 0.1% versus topical tacrolimus ointment 0.1% for treatment of refractory stable vitiligo. STUDY DESIGN: Comparative cross-sectional study. Place and Duration of the Study: Department of Dermatology, PNS Shifa, Karachi, Pakistan, from December 2022 to May 2023. METHODOLOGY: The study included 30 clinically diagnosed individuals of either gender who had refractory symptoms and aged between 20 and 60 years...
May 2024: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://read.qxmd.com/read/38707169/capecitabine-induced-genital-hand-foot-syndrome-treated-with-topical-tacrolimus
#2
Bryan L Chan, Tina Wang
We describe a rare case of capecitabine-induced palmar-plantar erythrodysesthesia (PPE), or hand-foot syndrome (HFS), involving the genitals, which resolved with tacrolimus therapy, in a patient with cT3dN3 stage IIIc moderately differentiated proximal rectal adenocarcinoma who was undergoing neoadjuvant chemotherapy. Given its severe impact on the quality of life, HFS often requires independent local anti-inflammatory treatment and subsequent dose delay and/or modification of the patient's chemotherapy...
April 2024: Curēus
https://read.qxmd.com/read/38690479/lichen-planus-of-the-eyelids-case-report-of-a-rare-presentation-of-a-common-dermatosis
#3
Nouf M AlEid, Omotoyosi N Ilesanmi, Mona A Alshehri, Ahmed A Alhumidi, Hind AlShihry
Lichen planus (LP) is a common T-cell-mediated autoimmune skin disease, and its exact etiology is unknown. Typically, it affects the trunk, flexural surfaces, and the mucosa.We report a rare finding of LP involving both eyelids in a 67-year-old female. A 67-year-old Saudi female with a medical history of diabetes mellitus, hypothyroidism and rheumatoid arthritis presented with a three-month history of pruritic skin eruptions in both eyelids. She had no associated musculoskeletal symptoms or fatigue and no medical or family history of atopy...
March 2024: Curēus
https://read.qxmd.com/read/38684438/-new-era-of-gvhd-prophylaxis-using-posttransplant-cyclophosphamide
#4
JOURNAL ARTICLE
Junichi Sugita
Use of posttransplant cyclophosphamide (PTCy) for the prophylaxis of graft-versus-host disease (GVHD) has revolutionized the field of HLA-haploidentical stem cell transplantation, which was previously considered high-risk and only feasible in specialized centers. The rapid adoption of PTCy is attributed not only to its superior efficacy in suppressing GVHD but also to its affordability and the lack of need for specialized techniques or equipment to administer it. Recently, PTCy has gained attention for its potential effectiveness in GVHD prophylaxis beyond HLA-haploidentical stem cell transplantation...
2024: [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology
https://read.qxmd.com/read/38681353/lichen-planus-pigmentosus-inversus-a-case-report-of-a-man-presenting-with-a-pigmented-lichenoid-axillary-inverse-dermatosis-plaid
#5
Philip R Cohen, Christof P Erickson, Antoanella Calame
Lichen planus pigmentosus is an uncommon subtype of lichen planus and lichen planus pigmentosus inversus is a rare variant of lichen planus pigmentosus. Lichen planus pigmentosus inversus typically presents as hyperpigmented patches or plaques, particularly in the intertriginous areas such as the axillae, the groin and inguinal folds, and in the submammary region. In some patients with lichen planus pigmentosus inversus, the condition can present as a pigmented lichenoid axillary inverse dermatosis (PLAID) when the lesions are in the axillae...
March 2024: Curēus
https://read.qxmd.com/read/38679243/formulation-development-of-nanostructured-lipid-carrier-based-nanogels-encapsulating-tacrolimus-for-sustained-therapy-of-psoriasis
#6
JOURNAL ARTICLE
Pratik Kakade, Vandana Patravale, Ajit Patil, John Disouza
The goal of this study was to formulate tacrolimus nanogel based on nanostructured lipid carrier (NLC) in order to improve the efficacy, aesthetic, and patient compliance for the treatment of psoriasis. The microemulsion method was used to create phase diagrams and NLCs were prepared using points obtained from the microemulsion region and characterized. The gelling agent carbopol was used to develop an NLC-based nanogel. The pH, drug assay, viscosity, spreadability, and in vitro release of the nanogel, were evaluated...
April 26, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38646215/a-case-of-palmoplantar-keratoderma-in-the-constellation-of-connective-tissue-diseases
#7
Ishan Verma, Amol H Dube, Sunita Kumbhalkar, Keshao Nagpure, Gitesh Sawatkar, Sachin R Chuadhari, Ashwini Umredkar
Overlap syndrome is a clinical challenge and brings together a wide range of treatment options for the treating physician. Addressing each and every complaint of the patient is crucial. A 50-year-old female patient presented with skin thickening, blackening, and hyperkeratosis; dysphagia; joint pain; features of myopathy; Raynaud's phenomenon; and dry mouth. Inflammatory markers were raised along with a positive antinuclear antibody (ANA) with Golgi apparatus pattern, anti-Sjögren's-syndrome-related antigen A (anti-SSA)/Ro60 3+, anti-SSA/Ro52 3+, and anti-PM/Scl 2+ antibodies that suggested overlap syndrome...
March 2024: Curēus
https://read.qxmd.com/read/38646109/vitiligo-in-a-patient-receiving-adalimumab-for-idiopathic-uveitis
#8
JOURNAL ARTICLE
Mehmet Fatih Kağan Değirmenci, Fatime Nilüfer Yalçındağ
In recent years, adalimumab has been increasingly used in the chronic treatment of non-infectious uveitis. This case report aimed to describe a drug-induced adverse event in a 34-year-old man who presented with blurred vision and floaters in the right eye and was being treated for intermediate uveitis. The patient had started topical treatment with a diagnosis of uveitis at another center. Best corrected visual acuity at presentation was 0.8 (decimal) in the right eye and 1.0 in the left eye. On examination, the anterior chamber in the right eye was clear, with anterior vitreous cells and mild haze, and snow banking and vitreous opacities in the inferior periphery...
April 19, 2024: Turkish Journal of Ophthalmology
https://read.qxmd.com/read/38642858/investigating-price-trends-and-cost-saving-opportunities-for-prescription-of-topical-calcineurin-inhibitors-using-the-truven-marketscan-database
#9
JOURNAL ARTICLE
David H Xiang, Helen Ji, Debby Cheng, Yevgeniy Semenov, Nicholas Theodosakis
No abstract text is available yet for this article.
April 18, 2024: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/38625674/peripheral-ulcerative-keratitis-associated-with-tralokinumab-therapy-a-case-report-and-review-of-il-13-inhibitor-associated-ocular-surface-disease
#10
JOURNAL ARTICLE
Nenita Maganti, Samuel A Whittier, Evan J Warner
BACKGROUND: Dupilumab and tralokinumab are interleukin-binding monoclonal antibodies used to treat systemic atopic disease. Use of these medications in management of atopic dermatitis (AD) is known to cause conjunctivitis. Dupilumab therapy has also been associated with more severe ocular surface disease, which has not previously been described in association with tralokinumab. This report describes a case of tralokinumab-associated conjunctivitis and peripheral ulcerative keratitis and reviews the spectrum and proposed mechanisms of ocular surface disease triggered by these medications...
April 16, 2024: Journal of Ophthalmic Inflammation and Infection
https://read.qxmd.com/read/38623137/comparison-of-efficacy-of-topical-betamethasone-dipropionate-and-topical-minoxidil-in-patients-with-alopecia-areata
#11
JOURNAL ARTICLE
Sana Aslam, Aqsa Z Awan, Madiha M Iqbal, Saira Saeed, Mariyam Saeed, Zartaj Liaqat, Saad Abdullah Dar, Salamat Ali, Muhammad Ahsan Asif, Haseeb Mehmood Qadri
Background and objective Alopecia areata (AA) is a reiterative and nonscarring type of hair loss that can affect any hairy area of the body, particularly the scalp. It manifests as patchy or confluent hair loss with variations in demographics and ethnicity. There are numerous treatment options available, including topical and systemic steroids, topical minoxidil, dithranol, tacrolimus, psoralen and ultraviolet therapy (PUVA), contact immunotherapy, and oral immunosuppressive drugs. However, no previous contrast for efficacy is present between the topical betamethasone versus topical minoxidil alone in our population...
March 2024: Curēus
https://read.qxmd.com/read/38577644/anal-pruritus-don-t-look-away
#12
EDITORIAL
Andreia Albuquerque
Anal pruritus is a common anorectal symptom that can significantly impair a patient's quality of life, including their mental health. It can be one of the most difficult proctological conditions to treat. Patients often delay seeking medical attention, since it is an embarrassing but non-life-threatening situation. Pruritus ani can be associated with idiopathic and secondary causes, such as anorectal diseases, cancer (anal or colorectal), dermatological and sexually transmitted diseases, fungal infections and systemic diseases...
March 16, 2024: World Journal of Gastrointestinal Endoscopy
https://read.qxmd.com/read/38562326/advancing-treatment-in-atopic-dermatitis-a-comprehensive-review-of-clinical-efficacy-safety-and-comparative-insights-into-corticosteroids-calcineurin-inhibitors-and-phosphodiesterase-4-inhibitors-as-topical-therapies
#13
REVIEW
Tyler D Hernandez, Sarah J Aleman, Maria Bao-Loc-Trung, Michael V Forte, William Brandt, Catherine Armstrong, Jeffrey Howard, Chizoba N Mosieri, Shahab Ahmadzadeh, Giustino Varrassi, Sahar Shekoohi, Alan D Kaye
Atopic dermatitis (AD) is a pervasive and multifaceted dermatological disorder causing daily distress to afflicted individuals worldwide. This comprehensive review synthesizes the historical and contemporary advancements in therapeutic strategies, offering a critical analysis of their efficacy, safety profiles, and adaptability. The enduring role of topical corticosteroids in managing AD is examined, acknowledging their potent anti-inflammatory properties alongside their potential adverse side effects, particularly in extended usage...
March 2024: Curēus
https://read.qxmd.com/read/38553411/clinical-pharmacokinetics-and-pharmacodynamics-of-topical-non-biological-therapies-for-psoriasis-patients
#14
REVIEW
Angela Lo, Jonathan D Greenzaid, Hannah Y Gantz, Kamran Chodri, Steven R Feldman
INTRODUCTION: Psoriasis is a chronic inflammatory cutaneous disease that causes patients psychosocial distress. Topical therapies are utilized for mild-to-moderate disease and for more severe disease in conjunction with systemic therapies. Topical corticosteroids are a cornerstone of treatment for psoriasis, but long-term use can cause stria and cutaneous atrophy and as well as systemic side effects such as topical steroid withdrawal. Non-steroidal topical therapies tend to be safer than topical corticosteroids for long-term use...
March 29, 2024: Expert Opinion on Drug Metabolism & Toxicology
https://read.qxmd.com/read/38550804/prescribing-patterns-in-the-treatment-of-topical-steroid-damaged-face-patients-a-cross-sectional-survey-based-observational-study-among-practicing-dermatologists-in-an-eastern-state-of-india
#15
JOURNAL ARTICLE
Chinmoy Raj, Maitreyee Panda, Bhabani S T P Singh, Bikash R Kar, Nibedita Patro
INTRODUCTION: Topical steroid damaged face (TSDF) is a common occurrence in the current scenario, where darker - skinned people believe having lighter-colored skin improves their prospects in all aspects of life. This has led to the abuse of topical corticosteroids with unrealistic expectations driven by ignorance of the adverse effects, particularly in the Indian population. As TSDF is virtually an epidemic in India and there is no treatment protocol for dermatologists, we conducted this study to find out what dermatologists prescribe and, in turn, serve as a foundation to develop guidelines in the future...
2024: Indian Dermatology Online Journal
https://read.qxmd.com/read/38542454/a-breakthrough-in-the-treatment-of-necrobiosis-lipoidica-update-on-treatment-etiopathogenesis-diagnosis-and-clinical-presentation
#16
REVIEW
Maciej Naumowicz, Stefan Modzelewski, Angelika Macko, Bartosz Łuniewski, Anna Baran, Iwona Flisiak
Necrobiosis lipoidica (NL) is a rare granulomatous disease of a not fully understood etiopathogenesis. Classically, NL is associated with insulin-dependent diabetes mellitus. The disease often fails to respond to conventional treatments and adversely affects patients' quality of life. First-line medications are usually topical corticosteroids, but patients respond to them with varying degrees of success. Other options include tacrolimus, phototherapy, cyclosporine, fumaric acid esters, and biologics (adalimumab, etanercept, and infliximab)...
March 20, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38541686/vernal-keratoconjunctivitis-immunopathological-insights-and-therapeutic-applications-of-immunomodulators
#17
REVIEW
Navpreet K Hehar, DeGaulle I Chigbu
Vernal keratoconjunctivitis (VKC) is a complex and multifactorial disease process that employs Th2 cell-mediated immunologic processes, which involves the overexpression of interleukin 4 (IL-4), IL-5, IL-9, IL-13, and IL-31, and the activation of mast cells that release IL-5 and CCL-11, recruiting eosinophils to the site of inflammation. The disease primarily affects young males and is more common in regions with warm climates. VKC is characterized by persistent and recurrent conjunctival inflammation that can adversely affect the patient's quality of life, and, when inadequately treated, may lead to a host of ocular complications, such as corneal shield ulcers and scarring...
March 9, 2024: Life
https://read.qxmd.com/read/38526543/use-of-lcp-tacrolimus-lcpt-in-kidney-transplantation-a-delphi-consensus-survey-of-expert-clinicians
#18
JOURNAL ARTICLE
Alexander Wiseman, Tarek Alhamad, Rita R Alloway, Beatrice P Concepcion, Matthew Cooper, Richard Formica, Christina L Klein, Vineeta Kumar, Nicolae Leca, Fuad Shihab, David J Taber, Sarah Mulnick, Donald M Bushnell, Monica Hadi, Suphamai Bunnapradist
BACKGROUND LCPT (Envarsus XR®) is a common once-daily, extended-release oral tacrolimus formulation used in kidney transplantation. However, there are minimal evidence-based recommendations regarding optimal dosing and treatment in the de novo and conversion settings. MATERIAL AND METHODS Using Delphi methodology, 12 kidney transplantation experts with LCPT experience reviewed available data to determine potential consensus topics. Key statements regarding LCPT use were generated and disseminated to the panel in an online Delphi survey...
March 12, 2024: Annals of Transplantation: Quarterly of the Polish Transplantation Society
https://read.qxmd.com/read/38522059/applications-of-topical-immunomodulators-enhance-clinical-signs-of-vernal-keratoconjunctivitis-vkc-and-atopic-keratoconjunctivitis-akc-a-meta-analysis
#19
REVIEW
Nir Erdinest, Dror Ben Ephraim Noyman, Naomi London, Itay Lavy, Nadav Levinger, David Landau, Abraham Solomon, Yair Morad, Shehzad A Naroo
PURPOSE: This meta-analysis aimed to review the safety and efficacy of topical cyclosporine A (CsA) and topical tacrolimus in allergic eye disease. METHODS: A systematic search identified thirteen studies and a total of 445 patients for inclusion, making this the largest meta-analysis published on the subject. The current review was performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). RESULTS: Thirteen randomized control trials were included in the meta-analysis...
March 24, 2024: International Ophthalmology
https://read.qxmd.com/read/38487167/commentary-a-comparative-randomized-clinical-trial-evaluating-the-efficacy-and-safety-of-tacrolimus-versus-hydrocortisone-as-a-topical-treatment-of-atopic-dermatitis-in-children
#20
COMMENT
Jane Harvey, Beth Stuart, Hywel C Williams
No abstract text is available yet for this article.
2024: Frontiers in Pharmacology
keyword
keyword
71401
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.